KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Cash from Operations: 2014-2024

Historic Cash from Operations for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$140.6 million.

  • BeOne Medicines' Cash from Operations rose 113.70% to $402.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $785.4 million, marking a year-over-year increase of 279.55%. This contributed to the annual value of -$140.6 million for FY2024, which is 87.85% up from last year.
  • According to the latest figures from FY2024, BeOne Medicines' Cash from Operations is -$140.6 million, which was up 87.85% from -$1.2 billion recorded in FY2023.
  • BeOne Medicines' Cash from Operations' 5-year high stood at -$140.6 million during FY2024, with a 5-year trough of -$1.5 billion in FY2022.
  • In the last 3 years, BeOne Medicines' Cash from Operations had a median value of -$1.2 billion in 2023 and averaged -$931.6 million.
  • In the last 5 years, BeOne Medicines' Cash from Operations tumbled by 125.47% in 2022 and then spiked by 87.85% in 2024.
  • BeOne Medicines' Cash from Operations (Yearly) stood at -$1.3 billion in 2020, then soared by 48.28% to -$663.8 million in 2021, then crashed by 125.47% to -$1.5 billion in 2022, then increased by 22.66% to -$1.2 billion in 2023, then soared by 87.85% to -$140.6 million in 2024.